Vytrus launch planned

Spanish biotech Vytrus Biotech, has received a favourable report on its compliance with the requirements for incorporation from the Market & Incorporations Coordination Committee.

This means that it will be able to launch on the BME Growth stock market, which lists SMEs in Spain, within a few weeks. 

The initial valuation is €12.2 million and the company’s shares will start trading with a reference value of €1.72/share once it has definitive approval of incorporation. Vytrus is specialised in active ingredients derived from plant stem cells for the cosmetic industry.

 

Latest Issues

Connex-C Asia 2025

Lee Kong Chian School of Medicine - Ong Tiong Tat and Irene Tan Liang Kheng Auditorium 11 Mandalay Road, Level 4, Singapore 308232
31 July - 1 August 2025

IFSCC Congress 2025

Palais des Festivals, Cannes
15th - 18th September 2025